Zusammenfassung
Über immunpathologische Begleiterkrankungen und -phänomene beim LED wird anhand eines Falles von LED und Myasthenia gravis (33jährige Patientin), 2 Fällen von LED und Thyreoiditis (42- bzw. 35jährige Patientinnen) und 7 bzw. 13 weiteren LED-Patienten berichtet. — Von 4 LED-Patienten mit positiven Rheumafaktoren waren 3 aus einer chronischen Polyarthritis rheumatica hervorgegangen. — Die nachgewiesenen Leuko- bzw. Thrombocytenagglutinine bei 3 bzw. 2 Patienten traten in 2 Fällen im Sinne autoantikörperbedingter Cytopenien kombiniert auf. — Faktoren gegen speciesunspezifische cytoplasmatische Fraktionen von Ratten-und Schweineleber waren mit der KBR nur in einem Falle unter Verwendung der Mikrosomen bzw. Mitochondrienfraktion als Antigen nachweisbar. — Die Schilddrüsenantikörper waren in dem einen Fall gegen menschliches Thyreoglobulin, im anderen Fall gegen die Mikrosomenfraktionen gesunder und kranker menschlicher Schilddrüsen sowie Thyreoglobulin einer Kolloidstruma gerichtet. — Die seltene Beobachtung eines LED, kombiniert mit Myasthenia gravis war Anlaß, die Beziehungen von Autoimmunleiden zur Thymusfunktion zu diskutieren.
Summary
One case of LED and myastenia gravis (Patient aged 33 years), two cases of LED and Thyroiditis (patients aged 42 and 35 years), and immunopathological phenomena of 13 patients with LED were reported. — 3 of 4 patients with LED and positive rheumatoid factors had in the preclinical phase of LED a history of rheumatoid arthritis. — There are leukocytagglutinins in 3 and plateletagglutinins in 2 patients. Both agglutinins were present in these patients. The cytopenia therefore seemed to be caused by autoantibodies. — Factors against species-unspecific cytoplasmatic fractions of rat and pig liver were found by complement fixation-test only in one case using the microsome and mitochondria fractions as antigen. — Thyroid-antibodies were directed against human thyreoglobulin in one case, and against the microsome fractions of normal and pathological human thyroid as well as thyreoglobulin of colloid goitre in another one. — The rare observation of LED and myastenia gravis gave rise to the discussion of the relation between autoimmun diseases and thymus function.
Literatur
Appelmans, F., andC. De Duve: Tissue fractionation studies; further observations on binding of acid phosphatase by rat-liver particles. Biochem. J.59, 426 (1955).
Asherson, G. L., andD. C. Dumonde: Characterisation of autoantibody produced in the rabbit by the injection of rat liver. Brit. J. exp. Path.43, 12 (1962).
Beickert, A.: Das Lupus erythematodes-Phänomen und die antinukleären Faktoren. Jena 1963.
Beutner, E. H., E. Witebsky, D. Ricken, andR. H. Adler: Studies on auto-antibodies in myastenia gravis. J. Amer. med. Ass.182, 46 (1962).
Boyden, S. V.: Effect of tannic acid in erythrocytes. J. exp. Med.89, 107 (1951).
Burnet, F. M.: Role of the thymus and related organs immunity. Brit. med. J.1962, 807.
Burnet, F. M., andI. R. Mackay: Lymphoepithelial structures and autoimmune disease. Lancet1962, 1030.
Casals, J., andR. Palacios: The complement fixation test in the diagnosis of virus infections of the central nervous system. J. exp. Med.74, 409 (1941).
Castleman, B.: Pathology of the thymus gland in myastenia gravis. Springfield (Ill.): Ch. C. Thomas 1960.
Daly, J. J., andE. Jackson: Case of Hashimoto's disease with myastenia gravis. Brit. med. J.1964 I, 748.
Dausset, J.: Normal and pathological platelet agglutinins in vestigates by means of the shaking method. Vox Sang. (Basel)4, 204 (1954).
Deicher, H., H. Holman, andH. Kunkel: Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases. Arthr. and Rheum.3, 1 (1960).
Denney, D., andR. L. Rose: Myastenia gravis followed by systemic lupus erythematosus; a case report. Neurology11, 710 (1961).
Donato Alovcón-Segovia, R. F. Gallsmith, J. E. Maldonato, andF. M. Howard: S.L. e. nach Thymektomie wegen Myasthenie. Lancet1963 II, 663.
Feltkamp, T. E. W., H. vander Geld, H. J. G. H. Oosterhuis, S. A. den Oudsten, andW. Hijmans: The serological overlap between rheumatoid arthritis and myastenia gravis. Acta rheum. scand., Suppl.8, 9 (1964).
Funkhauser, G. W.: Thymoma associated with myocarditis and the LE.-cellphenomenon: Report of case. New Engl. J. Med.264, 34 (1961).
Fuhrmann, W., u.J. Nawrotzki: Über neurologische Syndrome im Rahmen des Lupus erythematodes. Dtsch. Z. Nervenheilk.179, 444 (1959).
Grob, D.: Myastenia gravis. A review of pathogenesis and treatment. Arch. intern. Med.108, 171 (1961).
Hare, W. S. C., andI. R. Mackay: Radiological assessment of thymic size in myastenia gravis and systematic lupus erythematosus. Lancet1963 I, 746.
Hartl, W.: Zur Technik der Leukozyten-Agglutinationstests. Acta haemat. (Basel)28, 273 (1962).
Harvey, A. McG, L. E. Shulman, P. A. Tumulty, C. L. Conley, andE. M. Schoenrich: Systemic lupus erythematosus, review of the literature and clinical analysis of 138 cases. Medicine (Baltimore)33, 291 (1954).
Harvey, A. M., andR. J. Johns: Myastenia gravis and the thymus. Amer. J. Med.31, 1 (1962).
Hijans, W., D. Doniach, I. M. Roitt, andE. J. Holobrow: Serological overlap between lupus erythematosus, rheumatoid arthritis and thyroid autoimmune disease. Brit. med. J.1961 II, 7.
Kenneth, L. Becker, Jack L. Titus, William M. McConahey, andLewis B. Woolner: Morphologic evidence of thyroiditis in myasthenia gravis. J. Amer. med. Ass.187, 994 (1964).
Kenneth, L. Becker, R. H. Ferguson, andW. M. McConahey: Clinical observations on rheumatoid arthritis associated with Hashimoto's thyroiditis. Rochester, Minn., Wed.,38, No 9 (1963).
Kalbak, K.: Experimentelle og klinishe undersøgelser over o-streptolysin og forekomsten af o-antistreptolysin im Serum. Kopenhagen 1942.
Kornstad, L., andA. M. G. Kornstad: Thyroid autoimmunisation in patients suffring from rheumatoid arthritis and ankylosing spondylitis and in presumably healthy persons. Acta rheum. scand., Suppl.8, 77 (1964).
Kievits, J. H., andH. E. R. Schuit: A simple indirect LE-cell test with increased sensitivity. Bull. Soc. Internat. Transfus. Sang.2, 2288 (1957).
Larsson, Olle: Thymoma and systemic lupus erythematosus in the same patient. Lancet1963 II, 665.
Mackay, T. R., andP. He. Gail: Thymic germinal centres and plasma cells in systemic lupus erythematosus. Lancet1963, 667.
Marshall, A.H.E., andR. G. White: The immunological reactivity of the thymus. Brit. J. exp. Path.42, 379 (1961).
Mäkelä, T. E., R. Ruosteenoja, O. Wager, G. R. Wallgren, andE. J. Jokinen: Myastenia gravis and systemic lupus erythematosus. Acta med. scand.175, fasc. 6 (1964).
Meyer zum Büschenfelde, K. H., H. Behrend u.J. A. Bremer: Über Beziehungen zwischen Lupus erythematodes und Erkrankungen des lymphoretikulären Systems. Dtsch. Arch. klin. Med. (1965) (im Druck).
Messini, M. (Rom): Immunological significance of thymus. Delayed skin reaction in thymectomised rat. Lancet1964 I, 180.
Miescher, P., u.K. O. Vorlaender: Immunpathologie in Klinik und Forschung. Stuttgart: Georg Thieme 1961.
Miller, J. F. A. P., u.P. Dukor: Die Biologie des Thymus. Basel: S. Karger 1964.
Miller, J. F. A. P.: Immunity and the thymus. Lancet1963, 43.
Nastuk, W. L., A. J. L. Strauss, andK. E. Osserman: Search for a neuromuscular blocking agent in the blood of patients with myastenia gravis. Amer. J. Med.26, 394 (1959).
Nastuk, W. L., O. J. Plescia, andK. E. Osserman: Changes in serum complement activity in patients with myastenia gravis. Proc. Soc. exp. Biol. (N.Y.)105, 177 (1960).
Norris, E. M.: Thymoma and thymic hyperplasia in myastenia gravis with observations on general pathology. Amer. J. Cancer27, 421 (1936).
Ouchterlony, O.: Antigen-antibody-reaction in gels. Ark. Kemi (Stockh.)268, 1–9 (1948).
Piemme, Th. E.: Myastenia gravis and auto-immune disease. Ann. intern. Med.60, 130 (1964).
Rose, H. W., C. Ragan, E. Pearce, andM. D. Lipman: Differential agglutination of normal and sensitized sheep erythrocyts by sera of patients with rheumatoid arthritis. Proc. Soc. exp. Biol. (N.Y.)68 (I) (1948).
Robbins, W., H. Homan, H. Deicher, andH. Kunkel: Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc. Soc. exp. Biol. (N.Y.)96, 575 (1957).
Schölmerich, P., u.H. Deicher: Der Lupus erythematodes visceralis. In: Klinik der Gegenwart, Bd. VI, S. 639 (1963).
Scheiffarth, F., u.F. Legler: Serologie und klinische Erfahrung mit der Antistreptolysinreaktion. Ärztl. Wschr.2, 660 (1951).
Simpson, J. A.: Myastenia gravis: a new hypothesis. Scot. med. J.5, 419 (1960).
Singer, J. M., andC. M. Plotz: The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Amer. J. Med.21, 888 (1956).
Steffen, C.: Der Antiglobulin-Komsumptionstest. Seine theoretischen Grundlagen, Technik und Anwendungsbereiche. Klin. Wschr.40, 613 (1962).
Thomson, A. D.: Thymic origin of Hodgkin's disease. Brit. J. Cancer9, 37 (1955).
Feld, H. van der, andH. J. G. H. Oosterhuis: Muscle and thymus antibodies in myastenia gravis. Vox Sang8, 196 (1963).
Feld, H. van der, T. E. W. Felthamp, J. J. van Loghem, H. J. G. H. Oosterhuis, andA. Biemond: Multiple antibody production in myastenia gravis. Lancet1963 I, 373.
Waaler, E.: On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta path. microbiol. scand.17, 172 (1940).
Waksman, B. H., B. G. Arnason, andB. D. Jankovic: Role of thymus in immune reactions in rats. J. exp. Med.116, 159 (1962).
White, R. G., andA. H. E. Marshall: The autoimmune response in myastenia gravis. Lancet1962, 120.
White, R. G., B. H. Bass, E. Williams: London Hospital, London, E.1. Lymphadenoid goitre and the syndrome of systemic lupus erythematosus. Lancet1961 I, 368.
Zimmer, F. E., andM. M. Hargraves: The effect of blood coagulation on LE-cell formations. Proc. Mayo Clin.27, 424 (1952).
Author information
Authors and Affiliations
Additional information
Herrn Prof.Voit zum 70. Geburtstag gewidmet.
Die Untersuchungen wurden mit Unterstützung der Deutschen Forschungsgemeinschaft ausgeführt.
Rights and permissions
About this article
Cite this article
Meyer zum Büschenfelde, K.H., Gamp, A. & Schilling, F. Immunpathologische Begleiterkrankungen und -phänomene des Lupus erythematodes. Klin Wochenschr 43, 892–898 (1965). https://doi.org/10.1007/BF01711255
Issue Date:
DOI: https://doi.org/10.1007/BF01711255